IMI2 – Call 3

IMI2 – Call 3 was launched on 17 December 2014 with the following topics:

  • Remote assessment of disease and relapse – CNS [central nervous system]
    (part of the Remote Assessment of Disease and Relapse (RADAR) programme)
  • Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
  • Linking clinical neuropsychiatry and quantitative neurobiology
  • The consistency approach to quality control in vaccine manufacture
  • Pertussis vaccination research
  • Knowledge repository to enable patient focused medicine development

More information on the topics can be found in IMI’s press release and in the Call text. Other relevant documents, including documents for applicants, the list of expert reviewers, and the independent observers’ reports of the evaluations, can be found on the IMI2 Call documents page.

 

Projects

The projects resulting from IMI2 – Call 3 are:

  • PERISCOPE - Pertussis correlates of protection Europe
    factsheet | website
  • PRISM - Psychiatric ratings using intermediate stratified markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
    factsheet | website
  • RADAR-CNS - Remote assessment of disease and relapse in central nervous system disorders
    factsheet | website
  • RHAPSODY - Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
    factsheet | website
  • VAC2VAC - Vaccine lot to vaccine lot comparison by consistency testing
    factsheet | website

 

Call statistics

  • Proposals submitted: 38
  • Inadmissible & ineligible proposals: 3
  • Proposals recommended for funding: 6
  • Proposals not recommended for funding: 29